In 2008, Vogler et al. showed that XIAP knockdown can enhance the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced antitumor activity, which resulted in suppression of tumor growth if XIAP knockdown cells were treated with TRAIL [80]. Here, TNFSF10 is linked to neoplasm.